434 related articles for article (PubMed ID: 17140278)
1. Agomelatine: a preliminary review of a new antidepressant.
Zupancic M; Guilleminault C
CNS Drugs; 2006; 20(12):981-92. PubMed ID: 17140278
[TBL] [Abstract][Full Text] [Related]
2. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
Kasper S; Hamon M
World J Biol Psychiatry; 2009; 10(2):117-26. PubMed ID: 19255935
[TBL] [Abstract][Full Text] [Related]
3. Agomelatine, a melatonin agonist with antidepressant properties.
Dubovsky SL; Warren C
Expert Opin Investig Drugs; 2009 Oct; 18(10):1533-40. PubMed ID: 19758108
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder.
Olié JP; Kasper S
Int J Neuropsychopharmacol; 2007 Oct; 10(5):661-73. PubMed ID: 17477888
[TBL] [Abstract][Full Text] [Related]
5. [Agomelatine: the first "melatoninergic" antidepressant].
Bánki MC
Neuropsychopharmacol Hung; 2006 Oct; 8(3):105-12. PubMed ID: 17211046
[TBL] [Abstract][Full Text] [Related]
6. Treating each and every depressed patient.
Kennedy SH
J Psychopharmacol; 2008 Sep; 22(7 Suppl):19-23. PubMed ID: 18753279
[TBL] [Abstract][Full Text] [Related]
7. Agomelatine: innovative pharmacological approach in depression.
Popoli M
CNS Drugs; 2009; 23 Suppl 2():27-34. PubMed ID: 19708723
[TBL] [Abstract][Full Text] [Related]
8. Agomelatine: efficacy at each phase of antidepressant treatment.
Kennedy SH
CNS Drugs; 2009; 23 Suppl 2():41-7. PubMed ID: 19708725
[TBL] [Abstract][Full Text] [Related]
9. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.
Goodwin GM; Emsley R; Rembry S; Rouillon F;
J Clin Psychiatry; 2009 Aug; 70(8):1128-37. PubMed ID: 19689920
[TBL] [Abstract][Full Text] [Related]
10. Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients.
Quera-Salva MA; Lemoine P; Guilleminault C
Hum Psychopharmacol; 2010 Apr; 25(3):222-9. PubMed ID: 20373473
[TBL] [Abstract][Full Text] [Related]
11. Agomelatine in depression.
Smeraldi E; Delmonte D
Expert Opin Drug Saf; 2013 Nov; 12(6):873-80. PubMed ID: 24033095
[TBL] [Abstract][Full Text] [Related]
12. Agomelatine: new drug. Adverse effects and no proven efficacy.
Prescrire Int; 2009 Dec; 18(104):241-5. PubMed ID: 20020562
[TBL] [Abstract][Full Text] [Related]
13. The mechanism, efficacy, and tolerability profile of agomelatine.
MacIsaac SE; Carvalho AF; Cha DS; Mansur RB; McIntyre RS
Expert Opin Pharmacother; 2014 Feb; 15(2):259-74. PubMed ID: 24328686
[TBL] [Abstract][Full Text] [Related]
14. A benefit-risk assessment of agomelatine in the treatment of major depression.
Howland RH
Drug Saf; 2011 Sep; 34(9):709-31. PubMed ID: 21830835
[TBL] [Abstract][Full Text] [Related]
15. Agomelatine treatment of major depressive disorder.
Dolder CR; Nelson M; Snider M
Ann Pharmacother; 2008 Dec; 42(12):1822-31. PubMed ID: 19033480
[TBL] [Abstract][Full Text] [Related]
16. Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.
Lemoine P; Guilleminault C; Alvarez E
J Clin Psychiatry; 2007 Nov; 68(11):1723-32. PubMed ID: 18052566
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression.
Stein DJ; Picarel-Blanchot F; Kennedy SH
Hum Psychopharmacol; 2013 Mar; 28(2):151-9. PubMed ID: 23532747
[TBL] [Abstract][Full Text] [Related]
18. Melatonin receptor agonist agomelatine: a new drug for treating unipolar depression.
Bourin M; Prica C
Curr Pharm Des; 2009; 15(14):1675-82. PubMed ID: 19442180
[TBL] [Abstract][Full Text] [Related]
19. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development.
de Bodinat C; Guardiola-Lemaitre B; Mocaër E; Renard P; Muñoz C; Millan MJ
Nat Rev Drug Discov; 2010 Aug; 9(8):628-42. PubMed ID: 20577266
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of agomelatine in previously-treated depressed patients.
Kasper S; Hajak G
Eur Neuropsychopharmacol; 2013 Aug; 23(8):814-21. PubMed ID: 23820051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]